• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:
sino biological

Cell & Gene Therapy

Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Regenxbio
Biotech

In another reversal, FDA to reconsider Regenxbio gene therapy

The agency has reversed its previous demand that Regenxbio use an untreated control arm for the one-time Hunter syndrome candidate.
Angus Liu Jun 22, 2026 10:26am
red light green light

UniQure stock surges after FDA U-turn clears path to filing

Jun 17, 2026 9:10am
Eclipse

Intellia touts ‘paradigm-shifting’ HAE data

Jun 15, 2026 10:37am
caribou herd

Caribou boosts case for off-the-shelf CAR-T v. autologous

Jun 11, 2026 8:00am
Bubbles in boiling water

Big Pharma-backed SonoThera sounds off with $125M series B

Jun 10, 2026 10:48am
EULAR poster room

Cullinan's new data makes clearest case yet for autoimmune TCEs

Jun 6, 2026 5:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings